Similar articles for PMID: 26550791

Year	Number of Results
1994	1
1995	1
1997	1
1998	1
1999	1
2000	1
2002	1
2003	4
2004	4
2005	3
2006	5
2007	3
2008	8
2009	9
2010	6
2011	7
2012	6
2013	6
2014	14
2015	16
2016	19
2017	13
2018	18
2019	12
2020	6
2021	10
2022	14
2023	4
2024	2

1

The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition.

Khangholi S, Majid FA, Berwary NJ, Ahmad F, Aziz RB. Khangholi S, et al. Planta Med. 2016 Jan;82(1-2):32-45. doi: 10.1055/s-0035-1558086. Epub 2015 Nov 9. Planta Med. 2016. PMID: 26550791 Review.

2

Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications.

Abbas G, Al-Harrasi AS, Hussain H, Hussain J, Rashid R, Choudhary MI. Abbas G, et al. Pharm Biol. 2016;54(2):198-206. doi: 10.3109/13880209.2015.1028080. Epub 2015 Apr 8. Pharm Biol. 2016. PMID: 25853955 Review.

3

[Advanced glycation end products and hyperglycaemia].

Omsland TK, Bangstad HJ, Berg TJ, Kolset SO. Omsland TK, et al. Tidsskr Nor Laegeforen. 2006 Jan 12;126(2):155-8. Tidsskr Nor Laegeforen. 2006. PMID: 16415936 Free article. Review. Norwegian.

4

Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat.

Perez Gutierrez RM, de Jesus Martinez Ortiz M. Perez Gutierrez RM, et al. Pharm Biol. 2014 Nov;52(11):1435-44. doi: 10.3109/13880209.2014.895389. Epub 2014 Jul 15. Pharm Biol. 2014. PMID: 25026338

5

Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.

Brings S, Fleming T, Freichel M, Muckenthaler MU, Herzig S, Nawroth PP. Brings S, et al. Int J Mol Sci. 2017 May 5;18(5):984. doi: 10.3390/ijms18050984. Int J Mol Sci. 2017. PMID: 28475116 Free PMC article. Review.

6

Advanced glycation end-products and the progress of diabetic vascular complications.

Jakus V, Rietbrock N. Jakus V, et al. Physiol Res. 2004;53(2):131-42. Physiol Res. 2004. PMID: 15046548 Free article. Review.

7

[Advanced glycosylation end products and chronic complications of diabetes mellitus].

Méndez JD. Méndez JD. Gac Med Mex. 2003 Jan-Feb;139(1):49-55. Gac Med Mex. 2003. PMID: 12666409 Review. Spanish.

8

Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.

Ceriello A. Ceriello A. Diabetes Nutr Metab. 1999 Feb;12(1):42-6. Diabetes Nutr Metab. 1999. PMID: 10517306 Review.

9

Inhibitors of advanced glycation and endoplasmic reticulum stress.

Inagi R. Inagi R. Methods Enzymol. 2011;491:361-80. doi: 10.1016/B978-0-12-385928-0.00020-1. Methods Enzymol. 2011. PMID: 21329810

10

Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.

Babizhayev MA, Deyev AI, Savel'yeva EL, Lankin VZ, Yegorov YE. Babizhayev MA, et al. J Dermatolog Treat. 2012 Oct;23(5):345-84. doi: 10.3109/09546634.2010.521812. Epub 2011 Jul 14. J Dermatolog Treat. 2012. PMID: 21756141 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

171 results

Results by year